RAS(ON) Inhibitor Daraxonrasib Shows Promising Results in Advanced Pancreatic Cancer Phase 1/2 Study
The targeted RAS inhibitor daraxonrasib was found to be safe and showed signs of efficacy…
karnottMay 8, 2026
The Ragon is pleased to welcome Caroline Sokol, MD, PhD, as our newest faculty member.…
karnottMay 6, 2026
An experimental gene therapy for a rare form of genetic deafness has successfully restored hearing…
karnottMay 4, 2026
Two-year-old Miles is one of the first patients with hereditary hearing loss to receive gene…
karnottMay 4, 2026
Tufts University researchers are using AI and machine learning to more quickly identify potential narrow-spectrum…
karnottMay 1, 2026
The third-most common kind of childhood brain tumor, supratentorial ependymoma, is an aggressive cancer that…
karnottMay 1, 2026
A gene therapy designed by UMass Chan Medical school researchers to correct mutations that cause…
karnottApril 30, 2026
More than two in five U.S. adults have prediabetes, a condition marked by higher-than-normal blood…
karnottApril 30, 2026
What do Madagascar’s lemurs and the COVID-19 pandemic have in common? The answer is Amanda…
karnottApril 30, 2026
